Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, Thomas W.·2005·Nature Reviews Immunology

Cited by (742)

Items 101–200 of 742

  1. Self‐initiated use of topical cannabidiol oil for epidermolysis bullosa
    Malcolm Pyles Chelliah, Zachary A. Zinn, Phoung Khuu, Joyce M. C. Teng · 2018 · Pediatric Dermatology
  2. Effects of Cannabinoids on T-cell Function and Resistance to Infection
    Toby K. Eisenstein, Joseph J. Meissler · 2015 · Journal of Neuroimmune Pharmacology
  3. Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats
    M. Sanson, Lionel P. Bueno, Jean Fioramonti · 2006 · Neurogastroenterology & Motility
  4. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol.
    DeLong, Gerald T., Wolf, Carl E., Poklis, Alphonse, Lichtman, Aron H. · 2010 · Drug and Alcohol Dependence
  5. Anandamide Regulates Keratinocyte Differentiation by Inducing DNA Methylation in a CB1 Receptor-dependent Manner
    Andréa Paradisi, Nicoletta Pasquariello, Daniela Barcaroli, Mauro Maccarrone · 2007 · Journal of Biological Chemistry
  6. Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
    Ariane Mallat, Sophie Lotersztajn · 2007 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  7. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
    Sándor Bátkai, Mohanraj Rajesh, Partha Mukhopadhyay, György Haskó, Lucas Liaudet, Benjamin F. Cravatt, Anna Csiszár, Zoltan I. Ungvari, Pál Pacher · 2007 · American Journal of Physiology-Heart and Circulatory Physiology
  8. Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing
    Linlin Wang, Rui Zhao, Jiao-Yong Li, Shanshan Li, Min Liu, Meng Wang, Meng-Zhou Zhang, Wenwen Dong, Shukun Jiang, Miao Zhang et al. · 2016 · European Journal of Pharmacology
  9. Epigenetic control of skin differentiation genes by phytocannabinoids
    Mariangela Pucci, Cinzia Rapino, Andrea Di Francesco, Enrico Dainese, Claudio D’Addario, Mauro Maccarrone · 2013 · British Journal of Pharmacology
  10. Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review
    Marta Kruk-Słomka, Agnieszka Dzik, Barbara Budzyńska, Grażyna Biała · 2016 · Molecular Neurobiology
  11. Pharmacological and toxicological activities of α-humulene and its isomers: A systematic review
    Giovana Mendes de Lacerda, Maysa de Oliveira Barbosa, Maria Janice Pereira Lopes, Gyllyandeson de Araújo Delmondes, Daniel Souza Bezerra, Isaac Moura Araújo, Cícero Damon Carvalho de Alencar, Henrique Douglas Melo Coutinho, Laisla Rangel Peixoto, José Maria Barbosa‐Filho et al. · 2021 · Trends in Food Science & Technology
  12. Cannabinoid receptor activation leads to massive mobilization of myeloid‐derived suppressor cells with potent immunosuppressive properties
    Venkatesh L. Hegde, Mitzi Nagarkatti, Prakash S. Nagarkatti · 2010 · European Journal of Immunology
  13. Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
    Thuy Nguyen, Brian F. Thomas, Yanan Zhang · 2019 · Current Topics in Medicinal Chemistry
  14. Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism
    Kazuhide Hayakawa, Kenichi Mishima, Keiichi Irie, Mai Hazekawa, Shohei Mishima, Masayuki Fujioka, Kensuke Orito, Nobuaki Egashira, Shutaro Katsurabayashi, Kotaro Takasaki et al. · 2008 · Neuropharmacology
  15. Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke
    Ming Zhang, Billy R. Martin, Martin W. Adler, Raj J. Razdan, Weimin Kong, Doina Ganea, Ronald F. Tuma · 2009 · Journal of Neuroimmune Pharmacology
  16. Pharmacogenetic Trial of a Cannabinoid Agonist Shows Reduced Fasting Colonic Motility in Patients With Nonconstipated Irritable Bowel Syndrome
    Wong, Banny S., Camilleri, Michael, Busciglio, Irene, Carlson, Paula, Szarka, Lawrence A., Burton, Duane, Zinsmeister, Alan R. · 2011 · Gastroenterology
  17. Peripherally restricted CB1 receptor blockers
    Robert J. Chorvat · 2013 · Bioorganic & Medicinal Chemistry Letters
  18. Cannabinoids in the Pathophysiology of Skin Inflammation
    Cristian Scheau, Ioana Anca Bădărău, Livia-Gratiela Mihai, Andreea-Elena Scheau, Daniel Octavian Costache, Carolina Constantin, Daniela Cornelia Călina, Constantin Căruntu, Raluca Simona Costache, Ana Căruntu · 2020 · Molecules
  19. TRP channels as novel players in the pathogenesis and therapy of itch
    Tamás Bı́ró, Balázs István Tóth, Rita Marincsák, Nóra Dobrosi, Tamás Géczy, Ralf Paus · 2007 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  20. The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells
    Valerio Chiurchiù, Mirko Lanuti, Marco De Bardi, Luca Battistini, Mauro Maccarrone · 2014 · International Immunology
  21. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation
    Michael Camilleri, Paula Carlson, Sanna McKinzie, April Grudell, Irene A. Busciglio, Duane D. Burton, Kari L. Baxter, Michael D. Ryks, Alan R. Zinsmeister · 2007 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  22. Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator
    X Zhang, Yehoshua Maor, Wang Jf, George Kunos, JE Groopman · 2010 · British Journal of Pharmacology
  23. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
    Estrella García González, Enrico Selvi, Epifania Balistreri, Alfiya Akhmetshina, Katrin Palumbo, Sauro Lorenzini, Pietro Enea Lazzerini, Cinzia Montilli, Pier Leopoldo Capecchi, Monica Lucattelli et al. · 2012 · Annals of the Rheumatic Diseases
  24. The Cannabinoid Receptors Are Required for Ultraviolet-Induced Inflammation and Skin Cancer Development
    Duo Zheng, Ann M. Bode, Qing Jie Zhao, Yong‐Yeon Cho, Feng Zhu, Wei-Ya Ma, Zigang Dong · 2008 · Cancer Research
  25. Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
    Morgan A. Marks, Anil K. Chaturvedi, Karl T. Kelsey, Kurt Straíf, Julien Berthiller, Stephen M. Schwartz, Elaine Smith, Annah B. Wyss, Paul Brennan, Andrew F. Olshan et al. · 2013 · Cancer Epidemiology Biomarkers & Prevention
  26. Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
    Cassol-Jr, Omar J., Comim, Clarissa M., Silva, Bruno R., Hermani, Fernanda V., Constantino, Larissa S., Felisberto, Francine, Petronilho, Fabricia, Hallak, Jaime Eduardo C., De Martinis, Bruno S., Zuardi, Antonio W. et al. · 2010 · Brain Research
  27. Microfluidics for nanomedicines manufacturing: An affordable and low-cost 3D printing approach
    Mattia Tiboni, Massimiliano Tiboni, Alessio Pierro, Marco Papa, Simone Sparaventi, Marco Cespi, Luca Casettari · 2021 · International Journal of Pharmaceutics
  28. Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis
    J. Ludovic Croxford, Gareth Pryce, Samuel J. Jackson, Catherine A. Ledent, Gavin Giovannoni, Roger G. Pertwee, Takashi Yamamura, David Baker · 2007 · Journal of Neuroimmunology
  29. Cannabinoid system in the skin – a possible target for future therapies in dermatology
    Piotr Kupczyk, Adam Reich, Jacek Cezary Szepietowski · 2009 · Experimental Dermatology
  30. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats
    Yannick Marchalant, Francesca Cerbai, Holly M. Brothers, Gary L. Wenk · 2007 · Neurobiology of Aging
  31. The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
    Antonio Di Sabatino, Natalia Battista, Paolo Biancheri, Cinzia Rapino, Laura Rovedatti, Giuseppe Astarita, Alessandro Vanoli, Enrico Dainese, M. Guerci, Daniele Piomelli et al. · 2011 · Mucosal Immunology
  32. JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities
    Robert J. Chorvat, Jennifer Berbaum, Kristine Seriacki, John F. McElroy · 2012 · Bioorganic & Medicinal Chemistry Letters
  33. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
    Nicoleta Mirela Blebea, Andreea Iulia Pricopie, Robert-Alexandru Vlad, Gabriel Hancu · 2024 · International Journal of Molecular Sciences
  34. Cannabis smoking and respiratory health: Consideration of the literature
    Peter Gates, Adam Jaffé, Jan Copeland · 2014 · Respirology
  35. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation
    Yannick Marchalant, Susanna Rosi, Gary L. Wenk · 2006 · Neuroscience
  36. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment
    Gabriele D’Uva, Denisa Baci, Adriana Albini, Douglas McClain Noonan · 2017 · Cancer Treatment Reviews
  37. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors
    Maheswari Rajasekaran, Lisa K. Brents, Lirit N. Franks, Jeffery H. Moran, Paul L. Prather · 2013 · Toxicology and Applied Pharmacology
  38. Endocannabinoids and pregnancy.
    Taylor, Anthony H., Amoako, Akwasi A., Bambang, Katerina, Karasu, Tulay, Gebeh, Alpha, Lam, Patricia M.W., Marzcylo, Timothy H., Konje, Justin C. · 2010 · Clinica Chimica Acta
  39. Opportunities for cannabis in supportive care in cancer
    A. Kleckner, I. Kleckner, C. Kamen, M. Tejani, M. Janelsins, G. Morrow, L. Peppone · 2019 · Therapeutic Advances in Medical Oncology
  40. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα
    Mustafa A. Karwad, Tara Macpherson, Bo Wang, Elena Theophilidou, Sarir Sarmad, David A. Barrett, Michael Larvin, Karen L. Wright, Jonathan N. Lund, Saoirse Elizabeth O’Sullivan · 2016 · The FASEB Journal
  41. Therapeutics for neonatal brain injury
    Fernando F. Gonzalez, Donna Marie Ferriero · 2008 · Pharmacology & Therapeutics
  42. Antiproliferative Effects of Cannabinoid Agonists on Deep Infiltrating Endometriosis
    Mahaut Leconte, Carole Nicco, Charlotte Ngô, Sylviane Arkwright, Christiane Chéreau, Jean Guibourdenche, Bernard J. Weill, Charles Chapron, Bertrand E. Dousset, Frédéric Batteux · 2010 · American Journal Of Pathology
  43. It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
    Seyed Alireza Salami, Federico Martinelli, Antonio Giovino, Ava Bachari, Neda Arad, Nitin L. Mantri · 2020 · Molecules
  44. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma
    Jenny Flygare, Kristin Gustafsson, Eva K. Kimby, Birger Christensson, Birgitta Sander · 2005 · FEBS Letters
  45. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
    Kathleen L. McCoy · 2016 · Mediators of Inflammation
  46. Drug discovery and development with plant-derived compounds
    Olivier Potterat, Matthias O. Hamburger · 2007 · Birkhäuser Basel eBooks
  47. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
    Ewa Kozela, Ana Juknat, Fuying Gao, Nathali Kaushansky, Giovanni Coppola, Zvi Vogel · 2016 · Journal of Neuroinflammation
  48. Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
    Santosh V. Suryavanshi, Igor Kovalchuk, Olga Kovalchuk · 2021 · Frontiers in Immunology
  49. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo
    Theodore A. Sarafian, Nancy A. Habib, Michael J. Oldham, Navindra Persaud Seeram, Ru‐Po Lee, Laura Lin, Donald P. Tashkin, Michael D. Roth · 2006 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  50. Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK
    Young Sun Hwang, Youn‐Jung Kim, Mi‐Ok Kim, Mingyeong Kang, Sae Woong Oh, Youn Hwa Nho, See‐Hyoung Park, Jongsung Lee · 2017 · Chemico-Biological Interactions
  51. Activation of Cannabinoid CB2 Receptor Ameliorates Atherosclerosis Associated With Suppression of Adhesion Molecules
    Yan Zhao, Zuyi Yuan, Yan Liu, Jiahong Xue, Yuling Tian, Weimin Liu, Weiping Zhang, Yan Shen, Wei Xu, Xiao Liang et al. · 2010 · Journal of Cardiovascular Pharmacology
  52. Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis
    Sieglinde Marquart, Pawel Zerr, Alfiya Akhmetshina, Katrin Palumbo, Nicole Reich, Michal Tomčík, Angelika Horn, Clara Dees, Matthias Engel, Jochen Zwerina et al. · 2010 · Arthritis & Rheumatism
  53. Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation
    Gopinath Krishnan, Nivedita Chatterjee · 2012 · Glia
  54. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis
    Gui, Huan, Liu, Xia, Wang, Zhi-Wei, He, Dong-Yi, Su, Ding-Feng, Dai, Sheng-Ming · 2014 · Rheumatology
  55. Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors
    Evelyn Gaffal, Mira Cron, Nicole Glodde, Thomas Tüting · 2013 · Allergy
  56. Endocannabinoids: Effectors of glucocorticoid signaling
    Georgia Balsevich, Gavin N. Petrie, Matthew N. Hill · 2017 · Frontiers in Neuroendocrinology
  57. Neuroprotection in the Newborn Infant
    Fernando F. Gonzalez, Donna Marie Ferriero · 2009 · Clinics in Perinatology
  58. Cannabinoid receptors in acute and chronic complications of atherosclerosis
    François Mach, Fabrizio Montecucco, Sabine Steffens · 2007 · British Journal of Pharmacology
  59. The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats
    David Fernández‐López, María Ruth Pazos, Rosa Maria Tolón, María Ángeles Moro, Julián Romero, Ignacio Lizasoaín, José Antonio Martínez-Orgado · 2007 · Pediatric Research
  60. Combined effects of HIV and marijuana use on neurocognitive functioning and immune status
    April Denise Thames, Zanjbeel Mahmood, Alison C. Burggren, Ahoo Karimian, Taylor P. Kuhn · 2015 · AIDS Care
  61. CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy L. Koppel, Valérie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy T. Jimenez, Mark Stauber, Rachel Friedman, Peter Davies · 2013 · Molecular Medicine
  62. Pharmacological Synergism Between Cannabinoids and Paclitaxel in Gastric Cancer Cell Lines
    Hideyo Miyato, Joji Kitayama, Hiroharu Yamashita, Daisuke Souma, Masahiro Asakage, Jun Yamada, Hirokazu Nagawa · 2008 · Journal of Surgical Research
  63. Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
    Kun Li, Jia‐Yan Feng, Yongyu Li, Birol Yuece, Xuhong Lin, Liang-ying Yu, Yanna Li, Ya-jing Feng, Martin Storr · 2012 · Pancreas
  64. Type-2 cannabinoid receptors in neurodegeneration
    Tiziana Bisogno, Sergio Oddi, Alessandra Piccoli, Domenico Fazio, Mauro Maccarrone · 2016 · Pharmacological Research
  65. WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells
    A M Wasik, Stefan Almestrand, X Wang, Kjell R. Hultenby, Å-L Dackland, P Andersson, Eva K. Kimby, Birger Christensson, Birgitta Sander · 2011 · Cell Death and Disease
  66. Temporal variation in CB2R levels following T lymphocyte activation: Evidence that cannabinoids modulate CXCL12-induced chemotaxis
    Karen Coopman, Laura D. Smith, Karen L. Wright, Stephen Geoffrey Ward · 2006 · International Immunopharmacology
  67. Cannabinoids in acute gastric damage and pancreatitis.
    ARTUR B. DEMBINSKI, Zygmunt Warzecha, Piotr Ceranowicz, M Dembiński, Jakub Cieszkowski, Wiesław W. Pawlik, Stanislaw Jan Konturek, Romana Tomaszewska, Waldemar Hładki, Peter Ch Konturek · 2006 · PubMed
  68. Cannabinoid control of neuroinflammation related to multiple sclerosis
    David Baker, S J Jackson, Gareth Pryce · 2007 · British Journal of Pharmacology
  69. Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses
    Valerio Chiurchiù, Alessandro Leuti, Mauro Maccarrone · 2015 · Journal of Neuroimmune Pharmacology
  70. Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation
    Lucile Vincent, Derek Vang, Julia Nguyen, B.A. Benson, Jing-Xuan Lei, Kalpna Gupta · 2015 · Haematologica
  71. Cannabinoid Treatment Suppresses the T-Helper Cell-Polarizing Function of Mouse Dendritic Cells Stimulated with Legionella pneumophila Infection
    Tangying Lu, Cathy A. Newton, Izabella Perkins, Herman P. Friedman, Thomas Klein · 2006 · Journal of Pharmacology and Experimental Therapeutics
  72. Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis
    Aaron Gazendam, Nicholas W. Nucci, Kyle Gouveia, Hassaan Abdel Khalik, Luc Rubinger, Herman S. Johal · 2020 · Cannabis and Cannabinoid Research
  73. A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ
    Yuval Ramot, Koji Sugawara, Nóra Zákány, Balázs István Tóth, Tamás Bı́ró, Ralf Paus · 2013 · PeerJ
  74. CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis
    Balázs Csóka, Zoltán H. Németh, Partha Mukhopadhyay, Zoltán Spolarics, Mohanraj Rajesh, Stephanie Federici, Edwin A. Deitch, Sándor Bátkai, Pál Pacher, György Haskó · 2009 · PLoS ONE
  75. Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV
    Caitlin Wei‐Ming Watson, Emily W. Paolillo, Erin E. Morgan, Anya Umlauf, Erin E. Sundermann, Ronald J. Ellis, Scott Lee Letendre, Thomas D. Marcotte, Robert K. Heaton, Igor Grant · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
  76. Peroxisomal and Microsomal Lipid Pathways Associated with Resistance to Hepatic Steatosis and Reduced Pro-inflammatory State
    Diana Hall, Carine Poussin, Vidya Velagapudi, Christophe Empsen, Magali Joffraud, Jacques Samuel Beckmann, Albert E. Geerts, Yann Ravussin, Mark R. Ibberson, Matej Orešič et al. · 2010 · Journal of Biological Chemistry
  77. Glucocorticoids: Dr. Jekyll and Mr. Hyde of Hippocampal Neuroinflammation
    Alexey P. Bolshakov, Liya V. Tret’yakova, Alexey A. Kvichansky, Natalia V. Gulyaeva · 2021 · Biochemistry (Moscow)
  78. In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids
    Michelle Roche, Michael Diamond, John P. Kelly, David P. Finn · 2006 · Journal of Neuroimmunology
  79. Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1
    Verena Juliana Koller, Gerhard J. Zlabinger, Volker Auwärter, Sabine Fuchs, Siegfried Knasmüller · 2013 · Archives of Toxicology
  80. Expression of cannabinoid receptors type 1 and type 2 in non‐Hodgkin lymphoma: Growth inhibition by receptor activation
    Kristin Gustafsson, Xiao Wang, Denise Severa, Maeve Eriksson, Eva K. Kimby, Mats Merup, Birger Christensson, Jenny Flygare, Birgitta Sander · 2008 · International Journal of Cancer
  81. Cannabinoid Modulation of Neuroinflammatory Disorders
    Viviane M. Saito, Rafael Machado Rezende, Antônio Lúcio Teixeira · 2012 · Current Neuropharmacology
  82. Endocannabinoids in endocrine and related tumours
    Maurizio Bifulco, Anna Maria Malfitano, Simona Pisanti, Chiara Laezza · 2008 · Endocrine Related Cancer
  83. A Population-Based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma
    Caihua Liang, Michael D. McClean, Carmen J. Marsit, Brock C. Christensen, Edward S. Peters, Heather H. Nelson, Karl T. Kelsey · 2009 · Cancer Prevention Research
  84. Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
    Garcia-Gonzalez, E., Selvi, E., Balistreri, E., Lorenzini, S., Maggio, R., Natale, M.-R., Capecchi, P.-L., Lazzerini, P.-E., Bardelli, M., Laghi-Pasini, F. et al. · 2009 · Rheumatology
  85. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis
    Malek, Natalia, Mrugala, Monika, Makuch, Wioletta, Kolosowska, Natalia, Przewlocka, Barbara, Binkowski, Marcin, Czaja, Martyna, Morera, Enrico, Di Marzo, Vincenzo, Starowicz, Katarzyna · 2015 · Pain
  86. WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture
    Diana Aguirre-Rueda, Sol Guerra‐Ojeda, Martı́n Aldasoro, Antonio Iradi, Elena Obrador, María Dolores Mauricio, José M. Vila, Patricia Marchio, Soraya L. Vallés · 2015 · PLoS ONE
  87. Cannabinoid Receptor 2 (CB2) Mediates Immunoglobulin Class Switching from IgM to IgE in Cultures of Murine-Purified B Lymphocytes
    Marisela Agudelo, Cathy A. Newton, Ray H. Widen, Tracy A. Sherwood, Liang Nong, Herman P. Friedman, Thomas Klein · 2007 · Journal of Neuroimmune Pharmacology
  88. CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection
    Catherine A. Newton, Ping-Jen Chou, Izabella Perkins, Thomas Klein · 2008 · Journal of Neuroimmune Pharmacology
  89. Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
    Ariane Mallat, Fatima Teixeira-Clerc, Vanessa Deveaux, Sophie Lotersztajn · 2007 · Expert Opinion on Therapeutic Targets
  90. Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
    Joel Sardinha, Michael Eamon Kelly, Juan Zhou, Christine Lehmann · 2014 · Mediators of Inflammation
  91. Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation
    Andrea Mastinu, Marika Premoli, Giulia Ferrari‐Toninelli, Simone Tambaro, Giuseppina Maccarinelli, Maurizio Memo, Sara Anna Bonini · 2018 · Hormone Molecular Biology and Clinical Investigation
  92. Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood
    Ronald J. Ellis, Scott N. Peterson, Yueling Li, Rachel D. Schrier, Jenny Iudicello, Scott Lee Letendre, Erin E. Morgan, Bin Tang, Igor Grant, Mariana Cherner · 2020 · Neurology Neuroimmunology & Neuroinflammation
  93. New trends for the medical treatment of endometriosis
    Rocha, Ana Luiza L, Reis, Fernando M, Petraglia, Felice · 2012 · Expert Opinion on Investigational Drugs
  94. Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis
    Gui, Huan, Liu, Xia, Liu, Li-Rong, Su, Ding-Feng, Dai, Sheng-Ming · 2015 · Immunobiology
  95. A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors
    Carolina Echeverry, Giselle Prunell, Camila Narbondo, Verónica Sánchez de Medina, Xavier Nadal, Miguel Iván Reyes-Parada, Cecilia Scorza · 2020 · Neurotoxicity Research
  96. Effects of palmitoylation of Cys415in helix 8 of the CB1cannabinoid receptor on membrane localization and signalling
    Sergio Oddi, Enrico Dainese, Simone Laura Sandiford, Filomena Fezza, Mirko Lanuti, Valerio Chiurchiù, Antonio Totaro, Giuseppina Catanzaro, Daniela Barcaroli, Vincenzo De Laurenzi et al. · 2011 · British Journal of Pharmacology
  97. Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
    Ewa Kozela, Ana Juknat, Nathali Kaushansky, Avraham Ben‐Nun, Giovanni Coppola, Zvi Vogel · 2015 · Journal of Neuroinflammation
  98. CB 2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma
    Maria E. Ferrini, Sooyeon Hong, Andrea A. Stierle, Donald B. Stierle, Nephi Stella, K Roberts, Zeina H Jaffar · 2016 · Allergy
  99. Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system
    Katarzyna Starowicz, Barbara Przewłocka · 2012 · Philosophical Transactions of the Royal Society B Biological Sciences
  100. Lipopolysaccharide and cyclic AMP regulation of CB2 cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages
    Somnath Mukhopadhyay, Sucharita Das, Evelyn A. Williams, Duane Moore, Jenelle D. Jones, Daniel S. Zahm, Michael M. Ndengele, Andrew J. Lechner, A­llyn C. Howlett · 2006 · Journal of Neuroimmunology